Below are the most recent publications written about "Dyspepsia" by people in Profiles.
-
Schwartz PJ, Ackerman MJ, Antzelevitch C, Bezzina CR, Borggrefe M, Cuneo BF, Wilde AAM. Inherited cardiac arrhythmias. Nat Rev Dis Primers. 2020 07 16; 6(1):58.
-
Vigutto G, Lauro A, Vaccari S, Pirini MG, Diegoli M, D'Andrea V, Marino IR, Cervellera M, Tonini V. Giant Retroperitoneal Myelolipoma: An Unusual Diagnostic GI Challenge-Case Report and Review of the Literature. Dig Dis Sci. 2019 12; 64(12):3431-3435.
-
Peng AW, Juraschek SP, Appel LJ, Miller ER, Mueller NT. Effects of the DASH Diet and Sodium Intake on Bloating: Results From the DASH-Sodium Trial. Am J Gastroenterol. 2019 07; 114(7):1109-1115.
-
Bytzer P, Connolly SJ, Yang S, Ezekowitz M, Formella S, Reilly PA, Aisenberg J. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):246-52.e1-5.
-
Izgur V, Dass C, Solomides CC. Best cases from the AFIP: villous duodenal adenoma. Radiographics. 2010 Jan; 30(1):295-9.
-
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep 17; 361(12):1139-51.
-
Yakoob J, Jafri W, Abid S, Jafri N, Hamid S, Shah HA, Rizvi L, Islam M, Shaikh H. Giardiasis in patients with dyspeptic symptoms. World J Gastroenterol. 2005 Nov 14; 11(42):6667-70.
-
Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, Battikha JP, Hoffman H, Baggish J. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache. 2005 Sep; 45(8):973-82.
-
Andriulli A, Grossi E, Buscema M, Festa V, Intraligi NM, Dominici P, Cerutti R, Perri F. Contribution of artificial neural networks to the classification and treatment of patients with uninvestigated dyspepsia. Dig Liver Dis. 2003 Apr; 35(4):222-31.
-
Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000 Dec; 14(12):1653-61.